Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep.

Source:http://linkedlifedata.com/resource/pubmed/id/1687464

Eur. J. Pharmacol. 1991 Nov 19 205 1 11-6

Download in:

View as

General Info

PMID
1687464